News

The new Tempus software analyzes resting, non-ambulatory 12-lead ECG recordings to detect signs associated with having a low ...
Cardiologist explains that a heart attack isn't always fatal, and even patients with a very low survival chance can be saved with timely, advanced cardiac care.
Researchers at the German Center for Cardiovascular Research (DZHK) have identified a key molecule involved in a form of ...
Philips Cardiac Workstation July 17, 2025 Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution ...
The White House says President Trump underwent a medical exam because of swelling in his legs and has been diagnosed with a ...
“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...
TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.
NewYork-Presbyterian researchers have developed a deep learning model that increases doctors' abilities to diagnose ...
Philips (NYSE: PHG) today announced the launch of its new electrocardiogram (ECG) AI marketplace for cardiac care teams.
Cambridge, Mass.-based Royal Philips (NYSE: PHG), a global leader in health technology, today announced the launch of the Philips ECG AI Marketplace, a platform that gives cardiac care teams access to ...
The AI model effectively spotted all subtypes of amyloidosis in the dataset, with an area under the receiver-operating characteristic curve (AUROC) of 0.93, a sensitivity of 85% for identifying ...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue from sales ...